Vaccination with type-1 dendritic cells pulsed with multiple glioma-associated antigen peptides in combination with POLY-ICLC in patients with recurrent malignant glioma

被引：0
|
作者：
Okada, Hideho [1 ]
Lieberman, Frank [1 ]
Kalinski, Pawel [1 ]
Zhu, Xinmei [1 ]
Lunsford, L. Dade [1 ]
Kassam, Amin [1 ]
Mintz, Arlan
Bartlett, David [1 ]
Brown, Charles
Zeh, Herbert [1 ]
Whiteside, Theresa [1 ]
Butterfield, Lisa [1 ]
Hamilton, Ronald [1 ]
Salazar, Andres [2 ]
Pollack, Ian [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Oncovir Inc, Washington, DC USA
来源：
NEURO-ONCOLOGY | 2007年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：508 / 508
页数：1
相关论文
共 45 条
  • [31] A phase I trial of surgical resection with Gliadel Wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant glioma
    Rudnick, Jeremy D.
    Sarmiento, J. Manuel
    Uy, Benjamin
    Nuno, Miriam
    Wheeler, Christopher J.
    Mazer, Mia J.
    Wang, Hongqiang
    Hu, Jethro L.
    Chu, Ray M.
    Phuphanich, Surasak
    Black, Keith L.
    Yu, John S.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 74 : 187 - 193
  • [32] Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
    R Yamanaka
    T Abe
    N Yajima
    N Tsuchiya
    J Homma
    T Kobayashi
    M Narita
    M Takahashi
    R Tanaka
    British Journal of Cancer, 2003, 89 : 1172 - 1179
  • [33] Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: Results of a clinical phase I/II trial
    Yamanaka, R
    Homma, J
    Yajima, N
    Tsuchiya, N
    Tanaka, R
    MOLECULAR THERAPY, 2004, 9 : S98 - S98
  • [34] Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial
    Yamanaka, R
    Abe, T
    Yajima, N
    Tsuchiya, N
    Tsuchiya, N
    Homma, J
    Kobayashi, T
    Narita, M
    Takahashi, M
    Tanaka, R
    BRITISH JOURNAL OF CANCER, 2003, 89 (07) : 1172 - 1179
  • [35] Antigen-Specific Immune Responses and Clinical Outcome After Vaccination With Glioma-Associated Antigen Peptides and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Children With Newly Diagnosed Malignant Brainstem and Nonbrainstem Gliomas
    Pollack, Ian F.
    Jakacki, Regina I.
    Butterfield, Lisa H.
    Hamilton, Ronald L.
    Panigrahy, Ashok
    Potter, Douglas M.
    Connelly, Angela K.
    Dibridge, Sharon A.
    Whiteside, Theresa L.
    Okada, Hideho
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (19) : 2050 - U99
  • [36] A phase I trial of surgical resection with biodegradable carmustine (BCNU) wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant glioma
    Rudnick, J. D.
    Phuphanich, S.
    Chu, R.
    Mazer, M.
    Wang, H.
    Serrano, N.
    Francisco, M.
    Black, K. L.
    Wheeler, C.
    Yu, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [37] Cotransfection of Poly(I:C) and siRNA of IL-10 Into Fusions of Dendritic and Glioma Cells Enhances Antitumor T Helper Type 1 Induction in Patients With Glioma
    Akasaki, Yasuharu
    Kikuchi, Tetsuro
    Irie, Masaki
    Yamamoto, Yohei
    Arai, Takao
    Tanaka, Toshihide
    Joki, Tatsuhiro
    Abe, Toshiaki
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (02) : 129 - 136
  • [38] Peptide-pulsed dendritic cell vaccination targeting interleukin-13 receptor α2 chain in recurrent malignant glioma patients with HLA-A*24/A*02 allele
    Iwami, Kenichiro
    Shimato, Shinji
    Ohno, Masasuke
    Okada, Hideho
    Nakahara, Norimoto
    Sato, Yuichiro
    Yoshida, Jun
    Suzuki, Satoshi
    Nishikawa, Hiroyoshi
    Shiku, Hiroshi
    Natsume, Atsushi
    Wakabayashi, Toshihiko
    CYTOTHERAPY, 2012, 14 (06) : 733 - 742
  • [39] Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC
    Okada, Hideho
    Butterfield, Lisa H.
    Hamilton, Ronald L.
    Hoji, Aki
    Sakaki, Masashi
    Ahn, Brian J.
    Kohanbash, Gary
    Drappatz, Jan
    Engh, Johnathan
    Amankulor, Nduka
    Lively, Mark O.
    Chan, Michael D.
    Salazar, Andres M.
    Shaw, Edward G.
    Potter, Douglas M.
    Lieberman, Frank S.
    CLINICAL CANCER RESEARCH, 2015, 21 (02) : 286 - 294
  • [40] A phase II open labeled, randomized study of poly-ICLC matured dendritic cells for NY-ESO-1 and Mean-A peptide vaccination compared to Montanide, in melanoma patients in complete clinical remission.
    Pavlick, Anna C.
    Blazquez, Ana
    Meseck, Marcia
    Donovan, Michael J.
    Castillo-Martin, Mireia
    Thin, Tin Htwe
    Sabado, Rachel
    Mandeli, John P.
    Gnjatic, Sacha
    Friedlander, Philip Adam
    Bhardwaj, Nina
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345